Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-01-24 @ 3:48 AM
Study NCT ID:
NCT07218692
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-20
First Post:
2025-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Clear Cell Renal Cell Carcinoma | View |
| None | Advanced Renal Cell Carcinoma | View |
| None | Advanced Sarcomatoid Renal Cell Carcinoma | View |
| None | Metastatic Clear Cell Renal Cell Carcinoma | View |
| None | Metastatic Renal Cell Carcinoma | View |
| None | Metastatic Sarcomatoid Renal Cell Carcinoma | View |
| None | Recurrent Renal Cell Carcinoma | View |
| None | Stage III Renal Cell Cancer AJCC v8 | View |
| None | Stage IV Renal Cell Cancer AJCC v8 | View |
Keywords: